Endocannabinoid system--a novel target for cardiometabolic risk. | IMSEAR

Main content 1 Search 2 Footer 3

+A A -A High contrast

Endocannabinoid system--a novel target for cardiometabolic risk.

Joshi, Shashank R.

Article in En | IMSEAR | ID: sea-94477

Subject(s)

Appetite/drug effects; Appetite Stimulants/metabolism; Arachidonic Acids/metabolism; Calcium Channel Blockers/metabolism; Cardiovascular Diseases/metabolism; Endocannabinoids/metabolism; Humans; India; Lipid Metabolism; Obesity/drug therapy; Polyunsaturated Alkamides/metabolism; Receptors, Cannabinoid/antagonists & inhibitors; Risk Factors

Search on Google

Full text: 1 Index: IMSEAR Main subject: Appetite / Humans / Calcium Channel Blockers / Cardiovascular Diseases / Arachidonic Acids / Risk Factors / Appetite Stimulants / Receptors, Cannabinoid / Endocannabinoids / Lipid Metabolism Type of study: Etiology_studies / Risk_factors_studies Country/Region as subject: Asia Language: En Year: 2007 Type: Article

Search on Google

Full text: 1 Index: IMSEAR Main subject: Appetite / Humans / Calcium Channel Blockers / Cardiovascular Diseases / Arachidonic Acids / Risk Factors / Appetite Stimulants / Receptors, Cannabinoid / Endocannabinoids / Lipid Metabolism Type of study: Etiology_studies / Risk_factors_studies Country/Region as subject: Asia Language: En Year: 2007 Type: Article